Orally exhaled nitric oxide as a marker of inflammation in childhood asthma

M. Silvestri, F. Sabatini, L. Serpero, L. Petecchia, G. A. Rossi

Research output: Contribution to journalArticle

Abstract

Airway inflammation is a key process involved in asthma since mediators released by inflammatory cells may induce acute damages and structural changes to the airways. Airway inflammation is, therefore, a primary therapeutic goal and the treatment with anti-inflammatory drugs should be started as early as possible in order to avoid irreversible airway remodelling occurring during chronic inflammation, even in young children. The need to monitor inflammation has led to the exploration of volatile compound in exhaled air. Nitric oxide (NO) is being increasingly used to assess airway inflammation in childhood. Moreover, it has become clear in the last few years that increased NO is present in the expired air of patients with asthma and that measurement of the fractional concentration of exhaled NO (FENO) may represent a non invasive, simple, well tolerated test thought to reflect the airway inflammatory events in asthmatic children.

Original languageEnglish
Pages (from-to)233-244
Number of pages12
JournalMinerva Pneumologica
Volume42
Issue number4
Publication statusPublished - Dec 2003

Fingerprint

Nitric Oxide
Asthma
Inflammation
Air
Airway Remodeling
Anti-Inflammatory Agents
Therapeutics
Pharmaceutical Preparations

Keywords

  • Asthma
  • Child
  • Inflammation
  • Nitric oxide

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Orally exhaled nitric oxide as a marker of inflammation in childhood asthma. / Silvestri, M.; Sabatini, F.; Serpero, L.; Petecchia, L.; Rossi, G. A.

In: Minerva Pneumologica, Vol. 42, No. 4, 12.2003, p. 233-244.

Research output: Contribution to journalArticle

Silvestri, M. ; Sabatini, F. ; Serpero, L. ; Petecchia, L. ; Rossi, G. A. / Orally exhaled nitric oxide as a marker of inflammation in childhood asthma. In: Minerva Pneumologica. 2003 ; Vol. 42, No. 4. pp. 233-244.
@article{c5860c6589704a27b29894716b23d435,
title = "Orally exhaled nitric oxide as a marker of inflammation in childhood asthma",
abstract = "Airway inflammation is a key process involved in asthma since mediators released by inflammatory cells may induce acute damages and structural changes to the airways. Airway inflammation is, therefore, a primary therapeutic goal and the treatment with anti-inflammatory drugs should be started as early as possible in order to avoid irreversible airway remodelling occurring during chronic inflammation, even in young children. The need to monitor inflammation has led to the exploration of volatile compound in exhaled air. Nitric oxide (NO) is being increasingly used to assess airway inflammation in childhood. Moreover, it has become clear in the last few years that increased NO is present in the expired air of patients with asthma and that measurement of the fractional concentration of exhaled NO (FENO) may represent a non invasive, simple, well tolerated test thought to reflect the airway inflammatory events in asthmatic children.",
keywords = "Asthma, Child, Inflammation, Nitric oxide",
author = "M. Silvestri and F. Sabatini and L. Serpero and L. Petecchia and Rossi, {G. A.}",
year = "2003",
month = "12",
language = "English",
volume = "42",
pages = "233--244",
journal = "Minerva Pneumologica",
issn = "0026-4954",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Orally exhaled nitric oxide as a marker of inflammation in childhood asthma

AU - Silvestri, M.

AU - Sabatini, F.

AU - Serpero, L.

AU - Petecchia, L.

AU - Rossi, G. A.

PY - 2003/12

Y1 - 2003/12

N2 - Airway inflammation is a key process involved in asthma since mediators released by inflammatory cells may induce acute damages and structural changes to the airways. Airway inflammation is, therefore, a primary therapeutic goal and the treatment with anti-inflammatory drugs should be started as early as possible in order to avoid irreversible airway remodelling occurring during chronic inflammation, even in young children. The need to monitor inflammation has led to the exploration of volatile compound in exhaled air. Nitric oxide (NO) is being increasingly used to assess airway inflammation in childhood. Moreover, it has become clear in the last few years that increased NO is present in the expired air of patients with asthma and that measurement of the fractional concentration of exhaled NO (FENO) may represent a non invasive, simple, well tolerated test thought to reflect the airway inflammatory events in asthmatic children.

AB - Airway inflammation is a key process involved in asthma since mediators released by inflammatory cells may induce acute damages and structural changes to the airways. Airway inflammation is, therefore, a primary therapeutic goal and the treatment with anti-inflammatory drugs should be started as early as possible in order to avoid irreversible airway remodelling occurring during chronic inflammation, even in young children. The need to monitor inflammation has led to the exploration of volatile compound in exhaled air. Nitric oxide (NO) is being increasingly used to assess airway inflammation in childhood. Moreover, it has become clear in the last few years that increased NO is present in the expired air of patients with asthma and that measurement of the fractional concentration of exhaled NO (FENO) may represent a non invasive, simple, well tolerated test thought to reflect the airway inflammatory events in asthmatic children.

KW - Asthma

KW - Child

KW - Inflammation

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=1542319900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542319900&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:1542319900

VL - 42

SP - 233

EP - 244

JO - Minerva Pneumologica

JF - Minerva Pneumologica

SN - 0026-4954

IS - 4

ER -